We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Women's Healthcare Market Flourishes, But Innovation Still Needed

By MedImaging International staff writers
Posted on 05 Mar 2009
Twenty-five years of unprecedented medical advancements and global recognition has increased focus on the health of women worldwide, signifying a growing market for treatments to cure those diseases that affect women most. Now thriving, the total women's healthcare market is poised to exceed US$97 billion by 2013, according to a recent report.

The estimates were compiled by medical market research publisher Kalorama Information (New York, NY, USA). Kalorama's analysts looked at disorders that affect the female reproductive system and other disorders where there was at least a 70% preponderance of women affected by the condition. The 2013 forecasted figure equates to a compound annual growth rate (CAGR) of approximately 9% for the period beginning in 2008, when the women's healthcare market reached almost $64 billion.

Market strength is currently attributed to several industry segments, including rheumatoid arthritis treatments in the autoimmune disease segment, antivirals in the gynecologic infections and sexually transmitted disease (STD) segment, and treatments for osteoporosis. Sustained future growth will be supported by the aging of women globally and the expected increase in product demand as new product approvals and introductions provide a greater variety of options.

In spite of the clear advancement in women's healthcare, the need for continued innovation is palpable. Kalorama Information expects the next 10 years to progressively reflect significant changes in the market for new treatments combating women's health disorders, due largely to the growing empowerment of female consumers and the rising demand for safe and effective medications and lifestyle drugs.

"There's room for improvement,” noted Bruce Carlson, publisher of Kalorama Information. "Current research has opened potential breakthroughs, creating a new era of treatment possibilities. However, in many of the disorders routinely impacting women, current product offerings are simply mediocre.”

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of research services.

Related Links:

Kalorama Information



Adjustable Mobile Barrier
M-458
Biopsy Software
Affirm® Contrast
Medical Radiographic X-Ray Machine
TR30N HF
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.